OMEROS CORP
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 31, 2025
OMER$17.55+3.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(In thousands, except share and per share data)
| December 31, | December 31, | |
|---|---|---|
| 2024 | 2023 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $3,400 | $7,105 |
| Short-term investments | 86,732 | 164,743 |
| OMIDRIA contract royalty asset | 29,083 | 29,373 |
| Receivables | 7,739 | 8,096 |
| Prepaid expense and other assets | 7,166 | 8,581 |
| Total current assets | 134,120 | 217,898 |
| OMIDRIA contract royalty asset, non-current | 124,266 | 138,736 |
| Right of use assets | 14,961 | 18,631 |
| Property and equipment, net | 2,678 | 1,950 |
| Restricted investments | 1,054 | 1,054 |
| Total assets | $277,079 | $378,269 |
| Liabilities and shareholders’ equity (deficit) | ||
| Current liabilities: | ||
| Accounts payable | $5,905 | $7,712 |
| Accrued expenses | 26,005 | 31,868 |
| OMIDRIA royalty obligation | 20,645 | 8,576 |
| Term debt | 21,000 | — |
| Lease liabilities | 5,971 | 5,160 |
| Total current liabilities | 79,526 | 53,316 |
| OMIDRIA royalty obligation, non-current | 195,612 | 116,550 |
| Convertible senior notes, net | 97,178 | 213,155 |
| Term debt, non-current | 69,405 | — |
| Lease liabilities, non-current | 13,466 | 18,143 |
| Other accrued liabilities, non-current | 4,501 | 2,088 |
| Commitments and contingencies (Note 10) | ||
| Shareholders’ equity (deficit): | ||
| Preferred stock, par value $0.01 per share, 20,000,000 shares authorized; none issued and outstanding at December 31, 2024 and December 31, 2023 | — | — |
| Common stock, par value $0.01 per share, 150,000,000 shares authorized at December 31, 2024 and December 31, 2023; 58,044,465 and 61,128,597 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively. | 580 | 611 |
| Additional paid-in capital | 727,156 | 727,936 |
| Accumulated deficit | (910,345) | (753,530) |
| Total shareholders’ equity (deficit) | (182,609) | (24,983) |
| Total liabilities and shareholders’ equity (deficit) | $277,079 | $378,269 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.